These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 31284808)

  • 1. Drug stability testing and formulation strategies.
    Wu Z
    Pharm Dev Technol; 2018 Dec; 23(10):941. PubMed ID: 31284808
    [No Abstract]   [Full Text] [Related]  

  • 2. Formulation and Stability of Solutions.
    Akers MJ
    Int J Pharm Compd; 2016; 20(1):41-5. PubMed ID: 27127830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overview of drug product development.
    Narayan P
    Curr Protoc Pharmacol; 2011 Dec; Chapter 7():Unit 7.3.1-29. PubMed ID: 22147349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classification of solid dispersions: correlation to (i) stability and solubility (ii) preparation and characterization techniques.
    Meng F; Gala U; Chauhan H
    Drug Dev Ind Pharm; 2015; 41(9):1401-15. PubMed ID: 25853292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Manufacturing classification system (MCS): enabling better understanding of oral solid dosage formulation design.
    Leane M
    Pharm Dev Technol; 2024 Jun; 29(5):393-394. PubMed ID: 38738506
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclodextrin-Based Formulations: A Non-Invasive Platform for Targeted Drug Delivery.
    Muankaew C; Loftsson T
    Basic Clin Pharmacol Toxicol; 2018 Jan; 122(1):46-55. PubMed ID: 29024354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basic Principles of Lyophilization, Part 2.
    Akers MJ
    Int J Pharm Compd; 2016; 20(1):20-7. PubMed ID: 27125053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel strategies for the formulation and processing of poorly water-soluble drugs.
    Göke K; Lorenz T; Repanas A; Schneider F; Steiner D; Baumann K; Bunjes H; Dietzel A; Finke JH; Glasmacher B; Kwade A
    Eur J Pharm Biopharm; 2018 May; 126():40-56. PubMed ID: 28532676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basics of Compounding: Compounding Films.
    Allen LV
    Int J Pharm Compd; 2016; 20(4):298-305. PubMed ID: 28333675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basics of compounding: Tips and hints: powders, capsules, tablets, suppositories, and sticks, part 1.
    Allen LV
    Int J Pharm Compd; 2014; 18(1):42-5. PubMed ID: 24881340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From Lab Formulation Development to CTM Manufacturing of KO-947 Injectable Drug Products: a Case Study and Lessons Learned.
    Deng X; Ren P; Mai W; Wang Y; Zhang Y; Wu H; Xie Y; Chen H
    AAPS PharmSciTech; 2021 Jun; 22(5):168. PubMed ID: 34080070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solubility enhancement and solid-state characterisation.
    Tobyn M
    Pharm Dev Technol; 2018 Sep; 23(7):663. PubMed ID: 30106327
    [No Abstract]   [Full Text] [Related]  

  • 13. Examining drug hydrophobicity in continuous wet granulation within a twin screw extruder.
    Li H; Thompson MR; O'Donnell KP
    Int J Pharm; 2015 Dec; 496(1):3-11. PubMed ID: 26232701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A combined mathematical model linking the formation of amorphous solid dispersions with hot-melt-extrusion process parameters.
    Schittny A; Ogawa H; Huwyler J; Puchkov M
    Eur J Pharm Biopharm; 2018 Nov; 132():127-145. PubMed ID: 30240820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmaceutical Formulation Methods for Improving Retinal Drug Delivery.
    Stryjewski TP; Stefater JA; Eliott D
    Semin Ophthalmol; 2019; 34(4):218-222. PubMed ID: 31146619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Key considerations for optimization of formulation and melt-extrusion process parameters for developing thermosensitive compound.
    Ghosh I; Vippagunta R; Li S; Vippagunta S
    Pharm Dev Technol; 2012; 17(4):502-10. PubMed ID: 21284576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High throughput formulation: strategies for rapid development of stable protein products.
    Nayar R; Manning MC
    Pharm Biotechnol; 2002; 13():177-98. PubMed ID: 11987752
    [No Abstract]   [Full Text] [Related]  

  • 18. Ionic liquid-based formulation approaches for enhanced transmucosal drug delivery.
    Khan O; Bhawale R; Vasave R; Mehra NK
    Drug Discov Today; 2024 Sep; 29(9):104109. PubMed ID: 39032809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges in pediatric drug use: A pharmacist point of view.
    Balan S; Hassali MA; Mak VSL
    Res Social Adm Pharm; 2017; 13(3):653-655. PubMed ID: 27493130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carrageenan as an efficient drug release modifier for ethylcellulose-coated pharmaceutical dosage forms.
    Siepmann F; Muschert S; Zach S; Leclercq B; Carlin B; Siepmann J
    Biomacromolecules; 2007 Dec; 8(12):3984-91. PubMed ID: 18039003
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.